As Pfizer, a heavy hitter in U.S. politics, looks at a renewed bid to acquire U.K.-based AstraZeneca, the pharmaceutical giant sees the billions of dollars it could save in taxes if the deal goes through.Continue reading
This morning the White House released a new health care proposal that may be used as a blueprint for a... View ArticleContinue reading
More than a million spectators gathered before the Capitol on a frosty January afternoon to witness the inauguration of Barack... View ArticleContinue reading
Ferreting out safety problems with prescription drugs sooner–such as those that plagued the popular pain medication Vioxx–could be possible if... View ArticleContinue reading
Here at Real Time we are beginning to dig into examples of secret data--data the government collects, that could affect our health and safety, but we, the public, can't see.
The U.S. Food and Drug Administration (FDA) is a treasure house of data on the safety and efficacy of prescription drugs. Before a drug company can market a product in this country, it must first submit a plan to test the drug. Agency scientists review and analyze the results once they are submitted. Yet it's not always easy to get your hands on this information.
"One major ...Continue reading
Following up on President Obama’s January 21 memo requiring agencies to promote transparency and openness, the Food and Drug Administration... View ArticleContinue reading
Unless you or a family member has suffered a serious illness, it’s unlikely that you’ve run across the site ClinicalTrials.gov,... View ArticleContinue reading